Circulating miR-200 family and CTCs in metastatic breast cancer before, during, and after a new line of systemic treatment

The extracellular circulating microRNA (miR)-200 regulates epithelial-mesenchymal transition and, thus, plays an essential role in the metastatic cascade and has shown itself to be a promising prognostic and predictive biomarker in metastatic breast cancer (MBC). Expression levels of the plasma miR-...

Full description

Saved in:
Bibliographic Details
Main Authors: Fischer, Chiara (Author) , Turchinovich, Andrey (Author) , Feißt, Manuel (Author) , Riedel, Fabian (Author) , Haßdenteufel, Kathrin (Author) , Scharli, Philipp (Author) , Hartkopf, Andreas (Author) , Brucker, Sara (Author) , Michel, Laura L. (Author) , Burwinkel, Barbara (Author) , Schneeweiss, Andreas (Author) , Wallwiener, Markus (Author) , Deutsch, Thomas M. (Author)
Format: Article (Journal)
Language:English
Published: 23 August 2022
In: International journal of molecular sciences
Year: 2022, Volume: 23, Issue: 17, Pages: 1-12
ISSN:1422-0067
DOI:10.3390/ijms23179535
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms23179535
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/23/17/9535
Get full text
Author Notes:Chiara Fischer, Andrey Turchinovich, Manuel Feisst, Fabian Riedel, Kathrin Haßdenteufel, Philipp Scharli, Andreas D. Hartkopf, Sara Y. Brucker, Laura Michel, Barbara Burwinkel, Andreas Schneeweiss, Markus Wallwiener and Thomas M. Deutsch

MARC

LEADER 00000caa a2200000 c 4500
001 1819460215
003 DE-627
005 20230807133807.0
007 cr uuu---uuuuu
008 221020s2022 xx |||||o 00| ||eng c
024 7 |a 10.3390/ijms23179535  |2 doi 
035 |a (DE-627)1819460215 
035 |a (DE-599)KXP1819460215 
035 |a (OCoLC)1361695468 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fischer, Chiara  |d 1993-  |e VerfasserIn  |0 (DE-588)1270726439  |0 (DE-627)1819460142  |4 aut 
245 1 0 |a Circulating miR-200 family and CTCs in metastatic breast cancer before, during, and after a new line of systemic treatment  |c Chiara Fischer, Andrey Turchinovich, Manuel Feisst, Fabian Riedel, Kathrin Haßdenteufel, Philipp Scharli, Andreas D. Hartkopf, Sara Y. Brucker, Laura Michel, Barbara Burwinkel, Andreas Schneeweiss, Markus Wallwiener and Thomas M. Deutsch 
264 1 |c 23 August 2022 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.10.2022 
520 |a The extracellular circulating microRNA (miR)-200 regulates epithelial-mesenchymal transition and, thus, plays an essential role in the metastatic cascade and has shown itself to be a promising prognostic and predictive biomarker in metastatic breast cancer (MBC). Expression levels of the plasma miR-200 family were analyzed in relationship to systemic treatment, circulating tumor cells (CTC) count, progression-free survival (PFS), and overall survival (OS). Expression of miR-200a, miR-200b, miR-200c, miR-141, and miR-429, and CTC status (CTC-positive ≥ 5 CTC/7.5 mL) was assessed in 47 patients at baseline (BL), after the first completed cycle of a new line of systemic therapy (1C), and upon the progression of disease (PD). MiR-200a, miR-200b, and miR-141 expression was reduced at 1C compared to BL. Upon PD, all miR-200s were upregulated compared to 1C. At all timepoints, the levels of miR-200s were elevated in CTC-positive versus CTC-negative patients. Further, heightened miR-200s expression and positive CTC status were associated with poorer OS at BL and 1C. In MBC patients, circulating miR-200 family members decreased after one cycle of a new line of systemic therapy, were elevated during PD, and were indicative of CTC status. Notably, increased levels of miR-200s and elevated CTC count correlated with poorer OS and PFS. As such, both are promising biomarkers for optimizing the clinical management of MBC. 
650 4 |a circulating microRNA 
650 4 |a circulating tumor cells 
650 4 |a CTC 
650 4 |a EMT 
650 4 |a epithelial-mesenchymal transition 
650 4 |a MBC 
650 4 |a metastatic breast cancer 
650 4 |a microRNA-200 family 
650 4 |a miR-200 family 
650 4 |a miR-200s 
700 1 |a Turchinovich, Andrey  |d 1981-  |e VerfasserIn  |0 (DE-588)136061427  |0 (DE-627)577134795  |0 (DE-576)300807821  |4 aut 
700 1 |a Feißt, Manuel  |d 1989-  |e VerfasserIn  |0 (DE-588)1158520948  |0 (DE-627)1020533544  |0 (DE-576)504012312  |4 aut 
700 1 |a Riedel, Fabian  |d 1987-  |e VerfasserIn  |0 (DE-588)1117048381  |0 (DE-627)870923951  |0 (DE-576)478697007  |4 aut 
700 1 |a Haßdenteufel, Kathrin  |d 1994-  |e VerfasserIn  |0 (DE-588)1231317884  |0 (DE-627)1753999324  |4 aut 
700 1 |a Scharli, Philipp  |d 1995-  |e VerfasserIn  |0 (DE-588)1292166851  |0 (DE-627)1847545262  |4 aut 
700 1 |a Hartkopf, Andreas  |d 1979-  |e VerfasserIn  |0 (DE-588)139124101  |0 (DE-627)703216279  |0 (DE-576)309901596  |4 aut 
700 1 |a Brucker, Sara  |d 1974-  |e VerfasserIn  |0 (DE-588)122129660  |0 (DE-627)081754264  |0 (DE-576)293107386  |4 aut 
700 1 |a Michel, Laura L.  |d 1984-  |e VerfasserIn  |0 (DE-588)1018124888  |0 (DE-627)680395857  |0 (DE-576)355064529  |4 aut 
700 1 |a Burwinkel, Barbara  |d 1969-  |e VerfasserIn  |0 (DE-588)120685760  |0 (DE-627)704924005  |0 (DE-576)292337752  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Wallwiener, Markus  |d 1980-  |e VerfasserIn  |0 (DE-588)134044827  |0 (DE-627)692043934  |0 (DE-576)27468327X  |4 aut 
700 1 |a Deutsch, Thomas M.  |d 1988-  |e VerfasserIn  |0 (DE-588)1160897573  |0 (DE-627)1024291448  |0 (DE-576)506227960  |4 aut 
773 0 8 |i Enthalten in  |t International journal of molecular sciences  |d Basel : Molecular Diversity Preservation International, 2000  |g 23(2022), 17, Artikel-ID 9535, Seite 1-12  |h Online-Ressource  |w (DE-627)316340715  |w (DE-600)2019364-6  |w (DE-576)281194653  |x 1422-0067  |7 nnas  |a Circulating miR-200 family and CTCs in metastatic breast cancer before, during, and after a new line of systemic treatment 
773 1 8 |g volume:23  |g year:2022  |g number:17  |g elocationid:9535  |g pages:1-12  |g extent:12  |a Circulating miR-200 family and CTCs in metastatic breast cancer before, during, and after a new line of systemic treatment 
856 4 0 |u https://doi.org/10.3390/ijms23179535  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1422-0067/23/17/9535  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20221020 
993 |a Article 
994 |a 2022 
998 |g 1160897573  |a Deutsch, Thomas M.  |m 1160897573:Deutsch, Thomas M.  |d 910000  |d 910400  |e 910000PD1160897573  |e 910400PD1160897573  |k 0/910000/  |k 1/910000/910400/  |p 13  |y j 
998 |g 134044827  |a Wallwiener, Markus  |m 134044827:Wallwiener, Markus  |d 910000  |d 910400  |d 50000  |e 910000PW134044827  |e 910400PW134044827  |e 50000PW134044827  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 12 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |d 50000  |e 910000PS109972554  |e 910400PS109972554  |e 50000PS109972554  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 11 
998 |g 120685760  |a Burwinkel, Barbara  |m 120685760:Burwinkel, Barbara  |d 910000  |d 910400  |e 910000PB120685760  |e 910400PB120685760  |k 0/910000/  |k 1/910000/910400/  |p 10 
998 |g 1018124888  |a Michel, Laura L.  |m 1018124888:Michel, Laura L.  |d 910000  |d 910100  |e 910000PM1018124888  |e 910100PM1018124888  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 1292166851  |a Scharli, Philipp  |m 1292166851:Scharli, Philipp  |d 50000  |e 50000PS1292166851  |k 0/50000/  |p 6 
998 |g 1231317884  |a Haßdenteufel, Kathrin  |m 1231317884:Haßdenteufel, Kathrin  |d 910000  |d 910400  |e 910000PH1231317884  |e 910400PH1231317884  |k 0/910000/  |k 1/910000/910400/  |p 5 
998 |g 1117048381  |a Riedel, Fabian  |m 1117048381:Riedel, Fabian  |d 910000  |d 910400  |e 910000PR1117048381  |e 910400PR1117048381  |k 0/910000/  |k 1/910000/910400/  |p 4 
998 |g 1158520948  |a Feißt, Manuel  |m 1158520948:Feißt, Manuel  |d 910000  |d 911800  |e 910000PF1158520948  |e 911800PF1158520948  |k 0/910000/  |k 1/910000/911800/  |p 3 
998 |g 136061427  |a Turchinovich, Andrey  |m 136061427:Turchinovich, Andrey  |d 50000  |e 50000PT136061427  |k 0/50000/  |p 2 
998 |g 1270726439  |a Fischer, Chiara  |m 1270726439:Fischer, Chiara  |d 50000  |e 50000PF1270726439  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1819460215  |e 4199383964 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"recId":"316340715","id":{"issn":["1422-0067","1661-6596"],"eki":["316340715"],"zdb":["2019364-6"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"International journal of molecular sciences","title_sort":"International journal of molecular sciences"}],"origin":[{"dateIssuedDisp":"2000-","publisher":"Molecular Diversity Preservation International","publisherPlace":"Basel","dateIssuedKey":"2000"}],"part":{"year":"2022","volume":"23","issue":"17","extent":"12","pages":"1-12","text":"23(2022), 17, Artikel-ID 9535, Seite 1-12"},"language":["eng"],"note":["Gesehen am 17.09.20"],"pubHistory":["1.2000 -"],"disp":"Circulating miR-200 family and CTCs in metastatic breast cancer before, during, and after a new line of systemic treatmentInternational journal of molecular sciences","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"IJMS"}]}],"origin":[{"dateIssuedDisp":"23 August 2022","dateIssuedKey":"2022"}],"title":[{"title":"Circulating miR-200 family and CTCs in metastatic breast cancer before, during, and after a new line of systemic treatment","title_sort":"Circulating miR-200 family and CTCs in metastatic breast cancer before, during, and after a new line of systemic treatment"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"12 S."}],"id":{"doi":["10.3390/ijms23179535"],"eki":["1819460215"]},"person":[{"role":"aut","family":"Fischer","display":"Fischer, Chiara","given":"Chiara"},{"family":"Turchinovich","role":"aut","display":"Turchinovich, Andrey","given":"Andrey"},{"family":"Feißt","role":"aut","display":"Feißt, Manuel","given":"Manuel"},{"display":"Riedel, Fabian","given":"Fabian","family":"Riedel","role":"aut"},{"display":"Haßdenteufel, Kathrin","given":"Kathrin","family":"Haßdenteufel","role":"aut"},{"role":"aut","family":"Scharli","display":"Scharli, Philipp","given":"Philipp"},{"family":"Hartkopf","role":"aut","display":"Hartkopf, Andreas","given":"Andreas"},{"display":"Brucker, Sara","given":"Sara","role":"aut","family":"Brucker"},{"given":"Laura L.","display":"Michel, Laura L.","family":"Michel","role":"aut"},{"given":"Barbara","display":"Burwinkel, Barbara","family":"Burwinkel","role":"aut"},{"role":"aut","family":"Schneeweiss","display":"Schneeweiss, Andreas","given":"Andreas"},{"role":"aut","family":"Wallwiener","display":"Wallwiener, Markus","given":"Markus"},{"given":"Thomas M.","display":"Deutsch, Thomas M.","family":"Deutsch","role":"aut"}],"recId":"1819460215","note":["Gesehen am 20.10.2022"],"name":{"displayForm":["Chiara Fischer, Andrey Turchinovich, Manuel Feisst, Fabian Riedel, Kathrin Haßdenteufel, Philipp Scharli, Andreas D. Hartkopf, Sara Y. Brucker, Laura Michel, Barbara Burwinkel, Andreas Schneeweiss, Markus Wallwiener and Thomas M. Deutsch"]},"language":["eng"]} 
SRT |a FISCHERCHICIRCULATIN2320